MCF Advisors’s Zimmer Biomet ZBH Stock Holding History

MCF Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32.8K	Hold	380	–	–	﹤0.01%	776
2026 Q1	$34.5K	Buy	380 +160	+73%	+$14.7K	﹤0.01%	692
2025 Q4	$19.8K	Buy	+220	New	+$20.9K	﹤0.01%	695
2024 Q4	–	Sell	-3	Closed	-$325	–	1052
2024 Q3	$325	Hold	3	–	–	﹤0.01%	955
2024 Q2	$327	Hold	3	–	–	﹤0.01%	970
2024 Q1	$397	Buy	+3	New	+$375	﹤0.01%	925
2020 Q3	–	Sell	-6	Closed	-$1K	–	515
2020 Q2	$1K	Hold	6	–	–	﹤0.01%	466
2020 Q1	$1K	Hold	6	–	–	﹤0.01%	450
2019 Q4	$1K	Hold	6	–	–	﹤0.01%	439
2019 Q3	$1K	Hold	6	–	–	﹤0.01%	440
2019 Q2	$1K	Hold	6	–	–	﹤0.01%	432
2019 Q1	$1K	Hold	6	–	–	﹤0.01%	446
2018 Q4	$1K	Hold	6	–	–	﹤0.01%	469
2018 Q3	$1K	Hold	6	–	–	﹤0.01%	461
2018 Q2	$1K	Hold	6	–	–	﹤0.01%	430
2018 Q1	$1K	Hold	6	–	–	﹤0.01%	457
2017 Q4	$1K	Hold	6	–	–	﹤0.01%	469
2017 Q3	$1K	Hold	6	–	–	﹤0.01%	497
2017 Q2	$1K	Hold	6	–	–	﹤0.01%	489
2017 Q1	$1K	Buy	+6	New	+$680	﹤0.01%	442
2016 Q4	–	Sell	-39	Closed	-$5K	–	477
2016 Q3	$5K	Sell	39 -50	-56%	-$6.18K	﹤0.01%	374
2016 Q2	$10K	Buy	+89	New	+$10.1K	﹤0.01%	350

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MCF Advisors's ZBH Position: Q2 2026 in Review

MCF Advisors held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 380 shares worth $32.8K. The position accounts for ﹤0.01% of the portfolio, ranked #776.

MCF Advisors first reported a position in ZBH in Q2 2016 and has held it in 22 quarters since. The position peaked at $34.5K in Q1 2026. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

MCF Advisors held 380 shares of Zimmer Biomet worth $32.8K as of Q2 2026.
MCF Advisors left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #776 holding.
MCF Advisors first reported a position in Zimmer Biomet in Q2 2016 and has held it in 22 quarters since.
MCF Advisors's Zimmer Biomet position peaked at $34.5K in Q1 2026.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.